Loading viewer...
earnings
Format: PDF earnings
ResMed's Q4 FY2024 earnings presentation from August 1, 2024, covering financial results and forward-looking statements. The company focuses on digital health products and cloud-based software solutions for sleep apnea, COPD, and respiratory disease management, having impacted 178 million lives in the prior 12 months.
earnings
50 Pages
earnings
20 Pages
Prometic Life Sciences